# Pharmacogenetic Study of Bisoprolol in Egyptian Patients With Acute Coronary Syndrome

> **NCT05536271** · PHASE2 · COMPLETED · sponsor: **Damanhour University** · enrollment: 127 (actual)

## Conditions studied

- Acute Coronary Syndrome

## Interventions

- **DRUG:** Bisoprolol Fumarate

## Key facts

- **NCT ID:** NCT05536271
- **Lead sponsor:** Damanhour University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-09-01
- **Primary completion:** 2022-06-01
- **Final completion:** 2022-08-16
- **Target enrollment:** 127 (ACTUAL)
- **Last updated:** 2023-06-07

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05536271

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05536271, "Pharmacogenetic Study of Bisoprolol in Egyptian Patients With Acute Coronary Syndrome". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT05536271. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*